Science Explorer Back to mapMap
Discussion
Researcher · University Medical Center Utrecht · Netherlands

Richard van Hillegersberg

Richard van Hillegersberg publishes mostly in Surgery, Pulmonary and Respiratory Medicine and Oncology, on topics such as Esophageal Cancer Research and Treatment, Gastric Cancer Management and Outcomes and Esophageal and GI Pathology.

ORCID 0000-0002-7134-261X OpenAlex
World rank
#99,108
of 7,710,434 ranked researchers
Rank in Netherlands
#2,332
of 107,149
Works
869
Citations
26k
Citations per work
29.4
h-index
84
i10-index 450Top 0.2% in Surgery
Richard van Hillegersberg

What does Richard van Hillegersberg research?

Richard van Hillegersberg's work is mostly in Medicine (80%).

Health Sciences: 693 works · 79.8% of their workMedicine: 693 works · 79.8% of their workSurgery: 335 works · 38.5% of their workPulmonary and Respiratory Medicine: 182 works · 20.9% of their workOncology: 67 works · 7.7% of their workRadiology, Nuclear Medicine and Imaging: 42 works · 4.8% of their workGastroenterology: 37 works · 4.3% of their workHepatology: 31 works · 3.6% of their workEverything else: 176 works · 20.2% of their workTHEIR WORKRichard vanHillegersberg869works
Health Sciences80%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine69379.8%
  2. Everything else17620.2%
  1. 1Surgery38% of their works
  2. 2Pulmonary and Respiratory Medicine21% of their works
  3. 3Oncology8% of their works
  4. 4Radiology, Nuclear Medicine and Imaging5% of their works
  5. 5Gastroenterology4% of their works
  6. 6Hepatology4% of their works

Research topics

Which keywords describe Richard van Hillegersberg's research?

The keywords of their largest research topics: Endoscopic Resection, Neoadjuvant Therapy, Esophageal Carcinoma, Preoperative Chemoradiotherapy, Chemotherapy, Clinical Practice Guidelines, Adjuvant Therapy and Survival Analysis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 23 words, with their numbers
  1. Endoscopic Resection7532 topics
  2. Neoadjuvant Therapy5873 topics
  3. Esophageal Carcinoma4771 topic
  4. Preoperative Chemoradiotherapy4771 topic
  5. Chemotherapy4213 topics
  6. Clinical Practice Guidelines4053 topics
  7. Adjuvant Therapy3572 topics
  8. Survival Analysis3222 topics
  9. Gastric Cancer2761 topic
  10. Molecular Characterization2761 topic
  11. Endoscopic Stenting2271 topic
  12. Esophageal Perforation2271 topic
  13. Radiotherapy1272 topics
  14. Hepatocellular Carcinoma831 topic
  15. Liver Cancer831 topic
  16. CT Screening811 topic
  17. Imatinib Mesylate811 topic
  18. Lung Cancer811 topic
  19. Sunitinib811 topic
  20. Pancreatic Cancer641 topic
  21. Surgical Complications641 topic
  22. Breast Tumours461 topic
  23. Gene Expression461 topic

Where does Richard van Hillegersberg work?

Richard van Hillegersberg's main affiliation in the publication record is University Medical Center Utrecht, Netherlands.

How many publications and citations does Richard van Hillegersberg have?

OpenAlex counts 869 works and 25,551 citations for Richard van Hillegersberg, an h-index of 84, ranking #99,108 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Richard van Hillegersberg

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Richard van Hillegersberg. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.